Annexon
Price & Volume
Stats
See more52W Range | $2.04-$8.40 |
Market Cap | $769.1M |
Shares Short | 8M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.21 |
News
See moreYahoo Finance • 7 months ago
Turnstone Biologics Appoints William Waddill to its Board of Directors
Yahoo Finance • 7 months ago
10 Buy-Rated Stocks with Latest Insider Purchases
Yahoo Finance • 11 months ago
Annexon Outlines Global Registrational Program for ANX007 in Geographic Atrophy with FDA Alignment on Vision Preservation as Primary Endpoint
Yahoo Finance • 11 months ago
Annexon Reports Phase 1 Results for ANX1502, its Oral Small Molecule Inhibitor of the Classical Complement Pathway
About
CEO | Mr. Douglas Love Esq., J.D. |
CFO | Ms. Jennifer Lew |
Address | 1400 Sierra Point Parkway, Brisbane, CA, United States, 94005 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 71 |
